DBORX
Price
$24.59
Change
+$0.06 (+0.24%)
Updated
Jul 2 closing price
Net Assets
281.95M
RLBBX
Price
$36.39
Change
+$0.09 (+0.25%)
Updated
Jul 2 closing price
Net Assets
250.58B
Interact to see
Advertisement

DBORX vs RLBBX

Header iconDBORX vs RLBBX Comparison
Open Charts DBORX vs RLBBXBanner chart's image
BNY Mellon Balanced Opportunity I
Price$24.59
Change+$0.06 (+0.24%)
VolumeN/A
Net Assets281.95M
American Funds American Balanced R2
Price$36.39
Change+$0.09 (+0.25%)
VolumeN/A
Net Assets250.58B
DBORX vs RLBBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DBORX vs. RLBBX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBORX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 251B vs. DBORX (282M). DBORX pays higher dividends than RLBBX: DBORX (1.39) vs RLBBX (1.17). DBORX was incepted earlier than RLBBX: DBORX (21 years) vs RLBBX (23 years). RLBBX (1.32) is less costly to investors than DBORX (1.01). DBORX (46.25) and RLBBX (44.00) have comparable annual turnover. RLBBX has a lower initial minimum investment than DBORX: RLBBX (250) vs DBORX (1000). RLBBX annual gain was more profitable for investors over the last year : 7.11 vs. DBORX (4.35). RLBBX return over 5 years is better than : 36.40 vs. DBORX (15.80).
DBORXRLBBXDBORX / RLBBX
Total Expense Ratio0.901.3268%
Annual Report Gross Expense Ratio1.011.3277%
Fund Existence21 years23 years-
Gain YTD5.2347.14473%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets282M251B0%
Annual Yield % from dividends1.391.17118%
Returns for 1 year4.357.1161%
Returns for 3 years22.0831.8369%
Returns for 5 years15.8036.4043%
Returns for 10 years21.7657.0038%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSKN2.580.20
+8.40%
Strata Skin Sciences
CNF0.790.06
+8.08%
CNFinance Holdings Limited
REPL9.560.41
+4.43%
Replimune Group
WPM89.690.31
+0.35%
Wheaton Precious Metals Corp
KYMR44.530.09
+0.20%
Kymera Therapeutics